Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Details for Australian Patent Application No. 2009307884 (hide)

Owner Merck Sharp & Dohme Corp. Metabasis Therapeutics, Inc.

Inventors Bookser, Brett C.; Dang, Qun; Gibson, Tony S.; Jiang, Hongjian; Chung, De Michael; Bao, Jianming; Jiang, Jinlong; Kassick, Andy; Kekec, Ahmet; Lan, Ping; Lu, Huagang; Makara, Gergely M.; Romero, F. Anthony; Sebhat, Iyassu; Wilson, David; Wodka, Dariusz

Agent Spruson & Ferguson

Pub. Number AU-A-2009307884

PCT Pub. Number WO2010/047982

Priority 61/196,949 22.10.08 US

Filing date 12 October 2009

Wipo publication date 29 April 2010

International Classifications

A01N 43/50 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/047982 Priority application(s): WO2010/047982

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Metabasis Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307886-Micro-vitreoretinal trocar blade

2009307876-Mechanism of structural formation for metallic glass based composites exhibiting ductility